Scinai Immunotherapeutics Ltd. (SCNI)
0.754
+0.03
(+4.72%)
USD |
NASDAQ |
Feb 23, 12:58
Scinai Immunotherapeutics EPS Diluted (Quarterly) : -4.742 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Pluri, Inc. | -0.7066 |
| BioLineRx Ltd. | -0.223 |
| XTL Biopharmaceuticals Ltd. | -0.0292 |
| Can-Fite BioPharma Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.120M |
| Revenue (Quarterly) | 0.2773M |
| Total Expenses (Quarterly) | 2.397M |
| Enterprise Value | 7.888M |
| Profit Margin (Quarterly) | -764.5% |
| Earnings Yield | -1.63K% |